Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
01 2019
Historique:
received: 14 07 2018
revised: 22 10 2018
accepted: 28 11 2018
pubmed: 6 12 2018
medline: 28 5 2020
entrez: 6 12 2018
Statut: ppublish

Résumé

Tuberculosis (TB) is caused by Mycobacterium tuberculosis complex (MTBC), however, the distribution and frequency of MTBC lineages and sublineages vary in different parts of the globe. Mycobacterium africanum, a member of MTBC is responsible for a large percentage of TB cases in West Africa, however, it is rarely identified outside of this part of the World. Whether or not differential HLA polymorphism (an important host factor) is contributing to the geographic restriction of M. africanum to West Africa is unknown. Here, we conducted a cohort study in Mali of newly diagnosed individuals with active pulmonary TB and normal healthy controls. The MTBC isolates were spoligotyped to determine the TB study groups (M. tuberculosis sensu stricto LAM10 and M. africanum), and HLA typing was performed on peripheral blood. Unlike previous reports on other populations, we found that HLA class-I alleles were significantly associated with active TB disease in this population. HLA-B alleles (B*07:02, B*08:01, B*14:02, B*15:03, B*15:10, B*18:01, B*42:01, B*42:02, B*51:01 and B*81:01) were significantly associated with M. africanum (40%-45%) and M. tuberculosis (75%) compared with healthy controls. Many HLA-A alleles (A*02:05, A*34:02, A*66:01 and A*68:02) were also associated with both TB groups (65%-70%). However, many class II HLA-DR variants were found to be associated with M. tuberculosis but not M. africanum with the exception of the DRB1*03:01, which was associated with both groups. The differential HLA distribution observed in this study might be at least partially responsible for the geographical restriction of M. africanum infections to West Africa.

Identifiants

pubmed: 30516034
doi: 10.1111/tan.13448
pmc: PMC6333481
mid: NIHMS1003163
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-31

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL139994
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI110386
Pays : United States
Organisme : NIH HHS
ID : D71TW010428
Pays : United States
Organisme : FIC NIH HHS
ID : D71 TW010428
Pays : United States
Organisme : NIH HHS
ID : D43TW010350
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010350
Pays : United States
Organisme : NIH HHS
ID : R01AI110386
Pays : United States

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

J Infect Dis. 1983 Oct;148(4):676-81
pubmed: 6415179
BMC Infect Dis. 2016 Jan 23;16:23
pubmed: 26803588
J Clin Microbiol. 1999 Dec;37(12):3872-8
pubmed: 10565899
Tissue Antigens. 2011 Jun;77(6):562-71
pubmed: 21447146
J Clin Microbiol. 1997 Apr;35(4):907-14
pubmed: 9157152
Nature. 1991 Aug 15;352(6336):595-600
pubmed: 1865923
PLoS One. 2010 May 20;5(5):e10751
pubmed: 20505773
HLA. 2017 Sep;90(3):149-156
pubmed: 28612994
Genet Mol Res. 2015 Dec 03;14(4):15859-68
pubmed: 26634553
JAMA. 1998 Jan 21;279(3):226-8
pubmed: 9438744
Int J Tuberc Lung Dis. 2012 Jul;16(7):911-6
pubmed: 22508197
Int J Infect Dis. 2000;4(3):129-33
pubmed: 11179915
Emerg Infect Dis. 2004 May;10(5):921-3
pubmed: 15200832
PLoS Negl Trop Dis. 2010 Sep 28;4(9):e744
pubmed: 20927191
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2869-73
pubmed: 16477032
Tissue Antigens. 1995 Jan;45(1):1-11
pubmed: 7725305
PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004332
pubmed: 26751217
Rev Tuberc Pneumol (Paris). 1968 Mar;32(2):179-84
pubmed: 4985104
Nature. 1988 Aug 4;334(6181):395-402
pubmed: 3043226
Int J Mycobacteriol. 2017 Oct-Dec;6(4):379-386
pubmed: 29171452
FEMS Immunol Med Microbiol. 2010 Feb;58(1):102-5
pubmed: 20002176
Tissue Antigens. 1992 May;39(5):225-35
pubmed: 1357775
Nature. 2005 Oct 27;437(7063):1299-320
pubmed: 16255080
HLA. 2017 Aug;90(2):106-107
pubmed: 28378528
Eur J Immunogenet. 2002 Oct;29(5):431-4
pubmed: 12358854
Int J Tuberc Lung Dis. 2004 Aug;8(8):1017-21
pubmed: 15305487
Immunol Rev. 1982;66:39-56
pubmed: 6182089
Nat Genet. 2016 Mar;48(3):318-22
pubmed: 26829749
Tissue Antigens. 2009 Jul;74(1):73-80
pubmed: 19522772
Tissue Antigens. 2005 Aug;66(2):107-13
pubmed: 16029430
J Infect Dis. 2008 Oct 1;198(7):1037-43
pubmed: 18702608
PLoS Genet. 2013;9(3):e1003318
pubmed: 23505379
Nat Genet. 2010 Jun;42(6):498-503
pubmed: 20495566

Auteurs

Amadou Kone (A)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Bassirou Diarra (B)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Keira Cohen (K)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Seydou Diabate (S)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Bourahima Kone (B)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Mahamane T Diakite (MT)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Hawa Diarra (H)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Moumine Sanogo (M)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Antieme C G Togo (ACG)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Yeya Dit Sadio Sarro (YDS)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Bocar Baya (B)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Nadie Coulibaly (N)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Ousmane Kodio (O)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Chad J Achenbach (CJ)

Northwestern University, Chicago, Illinois.

Robert L Murphy (RL)

Northwestern University, Chicago, Illinois.

Jane L Holl (JL)

Northwestern University, Chicago, Illinois.

Sophia Siddiqui (S)

National Institute of Allergic and Infectious Diseases, Rockville, Maryland.

Seydou Doumbia (S)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

William R Bishai (WR)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Souleymane Diallo (S)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Mamoudou Maiga (M)

University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Northwestern University, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH